(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Jonas Oxgaard, Chemicals Equity Analyst at Sanford Bernstein, weighs in on Bayer AG's bid for Monsanto: he's not optimistic the deal will go through.

Warsh Says Inflation Isn’t Slowing, Vows to Reach 2% Target
15:10

Salesforce Jumps Most Since 2020 on Outlook, Anthropic Deal
21:35

Meta Says It Will Pay Up to $18 Billion Over Social Media Claims
25:02